A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human EGLN1/PHD2 The EGLN1/PHD2 Recombinant Protein Antigen is derived from E. coli. The EGLN1/PHD2 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-103819 |
|---|
| Réf. fabricant | 18222985 |
|---|
| Pureté | >80% by SDS-PAGE and Coomassie blue staining |
|---|
| Nom usuel | EGLN1 Recombinant Protein Antigen |
|---|
| Contenu et stockage | Store at −20°C long term. Avoid freeze-thaw cycles |
|---|
| Formule | In PBS (pH 7.4) containing 10% glycerol |
|---|
| À utiliser avec (application) | AC |
|---|
| Alias de gène | C1orf12, C1orf12HPH2 |
|---|
| Symbole de gène(s) | EGLN1 |
|---|
| Type d’étiquette | Unlabeled |
|---|
| Poids moléculaire | 27 kDa |
|---|
| Type de produit | Recombinant Protein Antigen |
|---|
| Quantité | 0.1mL |
|---|
| État réglementaire | RUO |
|---|
| Source | E.coli |
|---|
| Réactivité spécifique | This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-53727. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
